Types Of Licenses Available
If the invention desired by the company for commercial purposes
is claimed in a patent or patent application owned by the U.S. Government
the company must negotiate one of the following:
- Commercial Evaluation Licenses - grants the nonexclusive right
to make and use the technology for the purpose of evaluating its
commercial potential. The license is for a limited number of months
and does not grant the right to sell or otherwise distribute the
invention. Companies are required to obtain a commercial Patent
license for further use and/or development of the invention.
- Internal Commercial Use Licenses - grants a licensee the nonexclusive
right to make and use the invention for internal use only. These
licenses do not grant the right to sell or otherwise distribute
the invention, but allow the licensee to use the invention in
their commercial development activities.
- Nonexclusive and Exclusive Patent Licenses - allows a company
to commercialize the invention, under appropriate circumstances
pursuant to applicable statutes and regulations. An exclusive
license limits the use of the Invention to a single group or entity
while a non-exclusive license allows use by multiple concerns
If the invention desired by the company for commercial purposes
is not claimed in a patent or patent application owned by the U.S.
Government the company must negotiate a Biological Materials License
which allow a Company to make, use and /or sell commercially useful
biological material, which are not in the public domain and for
which patent protection cannot or will not be obtained. This type
of license typically is nonexclusive and facilitates the commercial
development of biological materials developed in PHS laboratories
without requiring that patent protection be obtained for every material
How To Obtain A License
A company that desires a license to develop a PHS invention must
complete and submit to the OTT an Application For License To Public
Health Service Inventions. This application forms the primary basis
for licensing decisions and provides the OTT with information about
the potential licensee, the type of license desired, and the proposed
development, marketing, and distribution strategy of the licensee.
Also, if the applicant desires exclusivity, the completed application
provides the OTT with the applicant's justification for an exclusive
license.
After reviewing the license application, the OTT, in consultation
with the IC that sponsored the research, determines if the applicant's
proposal is consistent with the licensing strategy developed for
the invention and whether the grant of the license would benefit
the public and be consistent with the interests of the Federal government.
If the applicant has requested a nonexclusive license and a favorable
review of the application is given by the OTT, negotiations will
generally begin within short order.
Request for exclusive or partially exclusive licenses require a
30 to 60 day notice be published in the Federal Register. Followingthe
required posted time, OTT will evaluate the application and all
comments received from the public to make a final determination
regarding the license. The criteria to be considered in evaluating
exclusive license applications (37 CFR 404.7) include:
- Does exclusive licensing serves the best interests of the public,
- Practical application of the invention is not likely to be
achieved under a nonexclusive license.
- An exclusive or partially exclusive license is a reasonable
and necessary incentive to promote the investment of business
capital expenditure by a company to develop the invention into
a commercially viable product.
- Exclusive or partially exclusive license terms and conditions
are not broader than necessary
- Exclusive licensing will not lessen competition.
Terms Included In The License
The OTT has developed several model license agreements that serve
as the basis for license negotiation. The business development plan
submitted as part of the license application process serves as the
basis for establishing performance benchmarks that are included
in the license agreement. The OTT works closely with licensees to
monitor performance and to adjust benchmarks, when appropriate,
to ensure the successful commercial development of PHS inventions.
Licenses are required to respond at least annually on their utilization
of or efforts to utilize license patent rights. These responses
are kept confidential and, to the extent permitted by law, are exempt
from disclosure under the Freedom of Information Act (5 U.S.C. §.552). |